TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)

Pharmaceutical products
Published value
Not published
Submission deadline Not published
Lots published5
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts): "Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)". Published status: complete. Published value: Value not published. 5 published lots. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityVelindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts)Scope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts)
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
5.2Bids / Report
0% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 26 active published awards; 26 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published9 Aug 2024, 15:26 BST
Last source update9 Aug 2024, 15:26 BST
Recurring procurementNot published
ClassificationPharmaceutical products
Delivery area
OCIDocds-h6vhtk-04368a
What is being bought
NHS Wales Framework Agreement for the supply of Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)
What changed
From the official release history
  1. Status changed to complete
    9 Aug 2024, 15:26 BST
  2. Official notice release published
    9 Aug 2024, 15:26 BST
  3. Submission deadline changed to published date
    9 Aug 2024, 15:26 BST
  4. Buyer information updated
    9 Aug 2024, 15:26 BST
  5. Status changed to active
    1 Feb 2024, 17:34 GMT
  6. Official notice release published
    1 Feb 2024, 17:34 GMT
  7. Submission deadline changed to 4 Mar 2024, 12:00 GMT
    1 Feb 2024, 17:34 GMT
  8. Buyer information updated
    1 Feb 2024, 17:34 GMT
Lots and requirements (5)
Published by the contracting authority
  • Lot 1 · #1
    Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) - Batch Products
    cancelled
    Published valueNot published
    Compounded Aseptic Medicines
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 2 · #2
    Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) - Batch Products
    cancelled
    Published valueNot published
    Compounded Aseptic products. Additional information: Compounded Aseptic products
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 3 · #3
    Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) - Batch Products
    cancelled
    Published valueNot published
    Compounded Aseptic products. Additional information: Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) - Batch Products
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 4 · #4
    Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) - Batch Products
    cancelled
    Published valueNot published
    Compounded Aseptic products
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 5 · #5
    Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) - Patient Specific Products
    cancelled
    Published valueNot published
    Compounded Aseptic Products
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    9 Aug 2024, 15:26 BST
  2. Award active
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Award active
    Not published · Not published
  5. Award active
    Not published · Not published
  6. Award active
    Not published · Not published
  7. Award active
    Not published · Not published
  8. Award active
    Not published · Not published
  9. Award active
    Not published · Not published
  10. Award active
    Not published · Not published
  11. Award active
    Not published · Not published
  12. Award active
    Not published · Not published
  13. Award active
    Not published · Not published
  14. Award active
    Not published · Not published
  15. Award active
    Not published · Not published
  16. Award active
    Not published · Not published
  17. Award active
    Not published · Not published
  18. Award active
    Not published · Not published
  19. Award active
    Not published · Not published
  20. Award active
    Not published · Not published
  21. Award active
    Not published · Not published
  22. Award active
    Not published · Not published
  23. Award active
    Not published · Not published
  24. Award active
    Not published · Not published
  25. Award active
    Not published · Not published
  26. Award active
    Not published · Not published
  27. Award active
    Not published · Not published
  28. Contract active
    Signed 31 Jul 2024, 00:00 BST · £5,965,196
  29. Contract active
    Signed 31 Jul 2024, 00:00 BST · £5,965,196
  30. Contract active
    Signed 31 Jul 2024, 00:00 BST · £19,145,096
  31. Contract active
    Signed 30 Jul 2024, 00:00 BST · £14,965,348
  32. Contract active
    Signed 30 Jul 2024, 00:00 BST · £19,145,096
  33. Contract active
    Signed 30 Jul 2024, 00:00 BST · £1,945,084
  34. Contract active
    Signed 30 Jul 2024, 00:00 BST · £1,945,084
  35. Contract active
    Signed 30 Jul 2024, 00:00 BST · £1,945,084
  36. Contract active
    Signed 30 Jul 2024, 00:00 BST · £1,945,084
  37. Contract active
    Signed 30 Jul 2024, 00:00 BST · £1,945,084
  38. Contract active
    Signed 30 Jul 2024, 00:00 BST · £5,965,196
  39. Contract active
    Signed 30 Jul 2024, 00:00 BST · £5,965,196
  40. Contract active
    Signed 30 Jul 2024, 00:00 BST · £14,965,348
  41. Contract active
    Signed 30 Jul 2024, 00:00 BST · £5,965,196
  42. Contract active
    Signed 30 Jul 2024, 00:00 BST · £5,965,196
  43. Contract active
    Signed 30 Jul 2024, 00:00 BST · £5,626,851
  44. Contract active
    Signed 30 Jul 2024, 00:00 BST · £5,626,851
  45. Contract active
    Signed 30 Jul 2024, 00:00 BST · £5,626,851
  46. Contract active
    Signed 30 Jul 2024, 00:00 BST · £5,626,851
  47. Contract active
    Signed 30 Jul 2024, 00:00 BST · £5,626,851
  48. Contract active
    Signed 30 Jul 2024, 00:00 BST · £14,965,348
  49. Contract active
    Signed 30 Jul 2024, 00:00 BST · £14,965,348
  50. Contract active
    Signed 30 Jul 2024, 00:00 BST · £14,965,348
  51. Contract active
    Signed 30 Jul 2024, 00:00 BST · £19,145,096
  52. Contract active
    Signed 30 Jul 2024, 00:00 BST · £19,145,096
  53. Contract active
    Signed 30 Jul 2024, 00:00 BST · £19,145,096
Commercial outcome and competition
Awards
Qualasept Ltd t/a Bath ASU
Not published · Not published · active
Lloyds Pharmacy Clinical Homecare
Not published · Not published · active
Qualasept Ltd t/a Bath ASU
Not published · Not published · active
Quantum Pharmaceutical Ltd
Not published · Not published · active
Baxter Healthcare Limited
Not published · Not published · active
ITH Pharma Ltd
Not published · Not published · active
Lloyds Pharmacy Clinical Homecare
Not published · Not published · active
Qualasept Ltd t/a Bath ASU
Not published · Not published · active
Baxter Healthcare Limited
Not published · Not published · active
Quantum Pharmaceutical Ltd
Not published · Not published · active
ITH Pharma Ltd
Not published · Not published · active
Baxter Healthcare Limited
Not published · Not published · active
Lloyds Pharmacy Clinical Homecare
Not published · Not published · active
Sciensus Ltd
Not published · Not published · active
Qualasept Ltd t/a Bath ASU
Not published · Not published · active
Baxter Healthcare Limited
Not published · Not published · active
Quantum Pharmaceutical Ltd
Not published · Not published · active
ITH Pharma Ltd
Not published · Not published · active
Lloyds Pharmacy Clinical Homecare
Not published · Not published · active
Quantum Pharmaceutical Ltd
Not published · Not published · active
ITH Pharma Ltd
Not published · Not published · active
Lloyds Pharmacy Clinical Homecare
Not published · Not published · active
Qualasept Ltd t/a Bath ASU
Not published · Not published · active
Baxter Healthcare Limited
Not published · Not published · active
Quantum Pharmaceutical Ltd
Not published · Not published · active
ITH Pharma Ltd
Not published · Not published · active
Contracts
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)
£5,965,196 · signed 31 Jul 2024, 00:00 BST · active
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)
£5,965,196 · signed 31 Jul 2024, 00:00 BST · active
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)
£19,145,096 · signed 31 Jul 2024, 00:00 BST · active
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)
£14,965,348 · signed 30 Jul 2024, 00:00 BST · active
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)
£19,145,096 · signed 30 Jul 2024, 00:00 BST · active
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)
£1,945,084 · signed 30 Jul 2024, 00:00 BST · active
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)
£1,945,084 · signed 30 Jul 2024, 00:00 BST · active
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)
£1,945,084 · signed 30 Jul 2024, 00:00 BST · active
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)
£1,945,084 · signed 30 Jul 2024, 00:00 BST · active
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)
£1,945,084 · signed 30 Jul 2024, 00:00 BST · active
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)
£5,965,196 · signed 30 Jul 2024, 00:00 BST · active
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)
£5,965,196 · signed 30 Jul 2024, 00:00 BST · active
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)
£14,965,348 · signed 30 Jul 2024, 00:00 BST · active
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)
£5,965,196 · signed 30 Jul 2024, 00:00 BST · active
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)
£5,965,196 · signed 30 Jul 2024, 00:00 BST · active
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)
£5,626,851 · signed 30 Jul 2024, 00:00 BST · active
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)
£5,626,851 · signed 30 Jul 2024, 00:00 BST · active
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)
£5,626,851 · signed 30 Jul 2024, 00:00 BST · active
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)
£5,626,851 · signed 30 Jul 2024, 00:00 BST · active
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)
£5,626,851 · signed 30 Jul 2024, 00:00 BST · active
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)
£14,965,348 · signed 30 Jul 2024, 00:00 BST · active
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)
£14,965,348 · signed 30 Jul 2024, 00:00 BST · active
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)
£14,965,348 · signed 30 Jul 2024, 00:00 BST · active
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)
£19,145,096 · signed 30 Jul 2024, 00:00 BST · active
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)
£19,145,096 · signed 30 Jul 2024, 00:00 BST · active
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)
£19,145,096 · signed 30 Jul 2024, 00:00 BST · active
Bid statistics
bids: 5 (lot 1)
bids: 5 (lot 1)
bids: 5 (lot 1)
bids: 5 (lot 1)
bids: 5 (lot 1)
bids: 5 (lot 2)
bids: 5 (lot 2)
bids: 5 (lot 2)
bids: 5 (lot 2)
bids: 5 (lot 2)
bids: 5 (lot 3)
bids: 5 (lot 3)
bids: 5 (lot 3)
bids: 5 (lot 3)
bids: 5 (lot 3)
bids: 6 (lot 4)
bids: 6 (lot 4)
bids: 6 (lot 4)
bids: 6 (lot 4)
bids: 6 (lot 4)
bids: 6 (lot 4)
bids: 5 (lot 5)
bids: 5 (lot 5)
bids: 5 (lot 5)
bids: 5 (lot 5)
bids: 5 (lot 5)
Buyer and organisations in this procedure

Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts)

Contracting authority GB-FTS-121161
View buyer profile
  • Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts)
    buyer
    centralPurchasingBody

    Medicines Value Unit, Imperial Park, IP5, Unit 5, Celtic Way,, Newport, UK, NP10 8BE
  • Baxter Healthcare Limited
    supplier

    Newbury, UK
  • ITH Pharma Ltd
    supplier

    London, UK
  • Lloyds Pharmacy Clinical Homecare
    supplier

    Harlow, UK
  • Qualasept Ltd t/a Bath ASU
    supplier

    Corsham, UK
  • Quantum Pharmaceutical Ltd
    supplier

    Durham, UK
  • Sciensus Ltd
    supplier

    Burton upon Trent, UK
  • Velindre NHS Trust, NHS Wales Shared Services Partnership — Procurement Services (on behalf of All Wales LHB's and Trusts
    reviewBody

    Newport
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published